Optimization of therapy in secondary progressive multiple sclerosis-Reference-Cited by-同舟云学术

Optimization of therapy in secondary progressive multiple sclerosis

Published:2024-08-07 Issue: Volume:16 Page:88-90
ISSN:2310-1342
Container-title:Neurology, Neuropsychiatry, Psychosomatics
language:
Short-container-title:RJTAO

Author:

Boyko A. N.¹^ORCID,Zyryanov S. K.²^ORCID,Vlasov Ya. V.³^ORCID

Affiliation:

1. N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Federal Center of Brain and Neurotechnologies, FMBA of Russia

2. Peoples' Friendship University of Russia named after Patrice Lumumba (RUDN University); City Clinical Hospital No. 24, Moscow City Healthcare Department

3. Samara State Medical University, Ministry of Health of Russia

Abstract

The article provides an analysis of modern methods of treatment of secondary progressive multiple sclerosis (SPMS). The only drug that has proven its effectiveness in all types of SPMS (with exacerbations and without exacerbations) is siponimod. Clinical trials of this drug have proven its efficacy and safety in this type of MS. If the drug is included in the list of high-cost technologies, this modern method of treating SPMS can be made available to all patients who need it.

Publisher

IMA Press, LLC

Reference16 articles.

1. Giovannoni G, Butzkueven H, Dhib-Jalbut S, et al. Brain health: time matters in multiple sclerosis. Mult Scler Relat Disord. 2016 Sep;9 Suppl 1:S5-S48. doi: 10.1016/j.msard.2016.07.003. Epub 2016 Jul 7.

2. Boyko A, Melnikov M. Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies. Brain Sci. 2020 May 18;10(5):305. doi: 10.3390/brainsci10050305

3. Koch-Henriksen N, Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol. 2021 Nov;17(11):676-88. doi: 10.1038/s41582-021-00556-y. Epub 2021 Sep 28.

4. Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28.

5. Власов ЯВ, Чураков МВ, Курапов МА и др. Первично-прогрессирующий рассеянный склероз в России: медико-социологическое исследование с участием пациентов и неврологов. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2018;118(8-2):40-6. doi: 10.17116/jnevro201811808240